ADHD
Long-Acting Methylphenidate Reduces Collision Rates of Young Adult Drivers With Attention-Deficit/Hyperactivity Disorder
Abstract: This study investigated whether methylphenidate delivered through a long-acting transdermal system (MTS) would reduce collision rates of young adult drivers with attention-deficit/hyperactivity disorder (ADHD).
Seventeen young adults completing the study (mean [SD] age, 20.82 [2.40] years; 14 men and 13 white) met the following inclusion criteria: ADHD diagnoses but not routinely taking ADHD medication, previously responsive to ADHD medication, active drivers with more than 1 collision or citation in the past 2 years, and no significant comorbidities.
Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD
Publication year: 2012Source:Drug and Alcohol DependenceIvan Berlin, Mei-Chen Hu, Lirio S. Covey, Theresa Winhusen
Differential expression of prostaglandin D2 synthase (PTGDS) in patients with attention deficit–hyperactivity disorder and bipolar disorder
Publication year: 2012Source: Journal of Affective Disorders, Available online 26 February 2012Juan Jesús Marín-Méndez, Ana Patiño-García, Victor Segura, Felipe Ortuño, Mª. Dolores Gálvez, ...
Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD
Publication year: 2012Source: Drug and Alcohol Dependence, Available online 23 February 2012Ivan Berlin, Mei-Chen Hu, Lirio S. Covey, Theresa Winhusen
New study looks at medication use of kids with autism, ADHD
Many children with an autism spectrum disorder (ASD) can benefit from medication for disorders such as attention-deficit/hyperactivity disorder (ADHD).
Identifying, diagnosing, and managing ADHD in college students.
Culpepper L | | |
Young children exposed to anesthesia multiple times show elevated rates of ADHD
Researchers have found that multiple exposures to anesthesia at a young age are associated with higher rates of attention-deficit/hyperactivity disorder (ADHD).
Associations of MAOA-VNTR or 5HTT-LPR alleles with attention-deficit hyperactivity disorder symptoms are moderated by platelet monoamine oxidase B activity
The monoamine systems have been suggested to play a role in the biological basis of attention-deficit hyperactivity disorder (ADHD) symptoms. Thus, polymorphisms, for example, in the monoamine oxidase A (MAOA) and the serotonin transporter (5HTT) genes have been associated with ADHD-like phenotypes. Furthermore, platelet monoamine oxidase B (MAOB) activity has frequently been linked to impulsiveness-related traits. In this study, we have studied ADHD symptoms with regard to the combination of platelet MAOB activity and MAOA-variable number of tandem repeats (VNTR) or 5HTT-LPR genotype.